Trademark: MODERNA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for MODERNA
We do not have any records of a proof of use for MODERNA at this moment.
Possible trademark infringements of MODERNA
Basic Information about MODERNA
- Serial Number
- 85741567
- Filing Date
- 28 Sep 2012
- Registration Number
- 4675783
- Registration Date
- 20 Jan 2015
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of MODERNA on the blockchain with WikiTrademarks.io.
- First use of MODERNA anywhere
- MODERNA was first used on 30 May 2013 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of MODERNA anywhere
- MODERNA was first used on 06 Dec 2012 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- B
- International Code
- 042
- US Codes
- 100; 101
Who owns MODERNA?
1. MODERNATX, INC. CAMBRIDGE MA
2. Moderna Therapeutics, Inc. Cambridge MA
3. Moderna Therapeutics, Inc. Cambridge MA
4. Moderna Therapeutics, Inc. Cambridge MA
Correspondent
- John Francis Ward
- Moderna
- 325 Binney Street
- Cambridge,MA 02142
Recent News about MODERNA
Why one letter could help Moderna avoid TM rejection Tweet this
Other Barks & Bites for Friday, March 24: Non-DOCX Fee Delayed Further; SCOTUS Petition Says Hirshfeld’s Review of PTAB Decision Violated Federal Vacancies Reform Act; Moderna CEO Grilled by Senate Committee over COVID Vaccine Price Hike Tweet this
Other Barks & Bites for Friday, December 9: United States Supports Delaying Decision on TRIPS IP Waiver Extension; Pfizer Countersues Moderna over Vaccines; Ericsson and Apple Settle Tweet this
Other Barks & Bites for Friday, November 4: CAFC Offers Mixed Bag in Uniloc Appeals, Global Music Copyright Market Valued at Nearly $40 Billion, and Moderna Loses Bid to Have U.S. Government Face Vaccine Patent Claims Tweet this
Moderna sues Pfizer, BioNTech over COVID-19 mRNA Vaccine Patents Tweet this
Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space Tweet this
This week in IP: Nokia hits 4,000 5G SEP families, Moderna and NIH debate patent creds, and more Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io